Chemotherapy for Leukemia Children on Elevated Creatinine Ureum Levels

  • Aslinda Aslinda Muhammadiyah University of Makassar
  • Ratna Mahmud Muhammadiyah University of Makassar
  • Harmawati Harmawati Muhammadiyah University of Makassar
  • Rahdiastuti Andi Patangai Muhammadiyah University of Makassar
  • Ayuni Maulidiya Muhammadiyah University of Makassar


This study aims to determine urea and creatine levels before and after chemotherapy in childhood leukemia. The research method used in this research is Quasi Experiment Pretest-posttest research. The results of the study show that based on the univariate analysis that has been carried out, it is known that the highest age of children with leukemia is school age (6-12 years). The most common gender of childhood leukemia is male, and the most common type of childhood leukemia is Acute Lymphoblastic Leukemia (ALL). Meanwhile, in the bivariate analysis after the Wilcoxon test, the p-value of urea levels before and after chemotherapy was 0.808 > 0.05, and the p-value of creatinine levels before and after chemotherapy was 0.1000 > 0.05. In conclusion, there is no difference in urea and creatinine levels before and after chemotherapy in children with leukemia.


Keywords: Chemotherapy, Ureum Creatinine, Childhood Leukemia


Algiraigri, A. H., Truong, T. H., & Lyon, M. E. (2021). Chemotherapy Readiness in Pediatric Oncology: Assessing an Automated Method to Measure Urine Specific Gravity. Hematology Oncology and Stem Cell Therapy, 14(2), 110–113.

Ballo, O., Eladly, F., Büttner, S., Stratmann, J. A., Rudolf, S., Brunnberg, U., Kreisel, E.-M., Steffen, B., Wagner, S., Finkelmeier, F., Serve, H., & Brandts, C. H. (2021). Acute Kidney Injury Adversely Affects the Clinical Course of Acute Myeloid Leukemia Patients Undergoing Induction Chemotherapy. Annals of Hematology, 100(5), 1159–1167.

Brown, P. A., Kairalla, J. A., Hilden, J. M., Dreyer, Z. A. E., Carroll, A. J., Heerema, N. A., Wang, C., Devidas, M., Gore, L., Salzer, W. L., Winick, N. J., Carroll, W. L., Raetz, E. A., Borowitz, M. J., Small, D., Loh, M. L., & Hunger, S. P. (2021). FLT3 Inhibitor Lestaurtinib Plus Chemotherapy for Newly Diagnosed Kmt2a-Rearranged Infant Acute Lymphoblastic Leukemia: Children’s Oncology Group Trial AALL0631. Leukemia, 35(5), 1279–1290.

Ford, M., Mauro, M., Aftandilian, C., Sakamoto, K. M., & Hijiya, N. (2022). Management of Chronic Myeloid Leukemia in Children and Young Adults. Current Hematologic Malignancy Reports, 17(5), 121–126.

Hamed, K. M., Dighriri, I. M., Baomar, A. F., Alharthy, B. T., Alenazi, F. E., Alali, G. H., Alenazy, R. H., Alhumaidi, N. T., Alhulayfi, D. H., Alotaibi, Y. B., Alhumaidan, S. S., Alhaddad, Z. A., Humadi, A. A., Alzahrani, S. A., & Alobaid, R. H. (2022). Overview of Methotrexate Toxicity: A Comprehensive Literature Review. Cureus.

Hermanto, H. D., Mayangsari, E., & Fadriyana, P. A. (2021). Side Effects of Carboplatin-Based Chemotherapy on Kidney Function in Gynaecological Cancer Patients. Majalah Kesehatan, 8(3), 137-148.

Hoeben, B. A. W., Pazos, M., Seravalli, E., Bosman, M. E., Losert, C., Albert, M. H., Boterberg, T., Ospovat, I., Mico Milla, S., Demiroz Abakay, C., Engellau, J., Jóhannesson, V., Kos, G., Supiot, S., Llagostera, C., Bierings, M., Scarzello, G., Seiersen, G. O. (2022). ESTRO ACROP and SIOPE recommendations for myeloablative Total Body Irradiation in children. Radiotherapy and Oncology, 173, 119–133.

Karol, S. E., Alexander, T. B., Budhraja, A., Pounds, S. B., Canavera, K., Wang, L., Wolf, J., Klco, J. M., Mead, P. E., Das Gupta, S., Kim, S. Y., Salem, A. H., Palenski, T., Lacayo, N. J., Pui, C. H., Opferman, J. T., & Rubnitz, J. E. (2020). Venetoclax in Combination with Cytarabine with or Without Idarubicin in Children with Relapsed or Refractory Acute Myeloid Leukaemia: A Phase 1, Dose-Escalation Study. The Lancet Oncology2, 21(4), 551–560.

Lam, S. Y., Chan, E. Y., Cheng, F. W. T., Ma, A. L. T., & Ha, S. Y. (2023). Acute Kidney Injury in Children with Haematological Malignancy: A Territory-Wide Study. Pediatric Nephrology, 38, 3823–3833.

Li, H., Xu, Q., Wang, Y., Chen, K., & Li, J. (2020). Serum Neutrophil Gelatinase-Associated Lipocalin (Ngal) As A Biomarker for Predicting High Dose Methotrexate Associated Acute Kidney Injury in Children with Acute Lymphoblastic Leukemia. Cancer Chemotherapy and Pharmacology, 85(1), 95–103.

Limratchapong, C., Sophark, P., Vachvanichsanong, P., McNeil, E. B., & Chotsampancharoen, T. (2022). Acute Kidney Injury and Childhood Acute Myeloid Leukemia. Pediatric Nephrology, 37(11), 2765–2770.

M’harzi, S., Elouali, A., Lahrache, K., Ghanam, A., Babakhouya, A., Rkain, M., & Benajiba, N. (2022). Acute Pancreatitis Following L-Asparaginase in Acute Lymphoblastic Leukemia. Leukemia Research Reports, 18.

Nuraini, D., & Mariyam, M. (2020). Physiological Impact of Post Chemotherapy in Children with Acute Lymphocytic Leukaemia (LLA). Ners Muda, 1(2), 120.

Pojoh, V. S., Mantik, M. F. J., & Manoppo, J. I. C. (2019). Relationship between Body Mass Index and the Achievement of Remission in Children with Acute Lymphoblastic Leukaemia. E-CliniC, 8(1).

Queudeville, M., & Ebinger, M. (2021). Blinatumomab in pediatric acute Lymphoblastic Leukemia-from Salvage to First Line Therapy (A Systematic Review). Journal of Clinical Medicine, 10(12).

Rubnitz, J. E., & Kaspers, G. J. L. (2021). How I Treat Pediatric Acute Myeloid Leukemia. Blood, 138(12), 1009–1018.

Shields, L. B. E., Peppas, D. S., & Rosenberg, E. (2019). Pelvic Neuroblastoma Presenting with Acute Urinary Retention and Acute Kidney Injury. Urology Case Reports, 23, 82–84.

Thastrup, M., Duguid, A., Mirian, C., Schmiegelow, K., & Halsey, C. (2022). Central Nervous System Involvement in Childhood Acute Lymphoblastic Leukemia: Challenges and Solutions. Leukemia, 36(12), 2751–2768.

Vijayasekharan, K., Bhat K, V., Venkatagiri, A. M., Godkhindi, V. M., Laxminarayana, S. L. K., & Belurkar, S. (2021). Bilateral Massive Nephromegaly–A Rare Presentation of T-Cell Acute Lymphoblastic Leukemia. Leukemia Research Reports, 15.

Yang, W., Cai, J., Shen, S., Gao, J., Yu, J., Hu, S., Jiang, H., Fang, Y., Liang, C., Ju, X., Wu, X., Zhai, X., Tian, X., Wang, N., Liu, A., Jiang, H., Jin, R., Sun, L., Yang, M., & Pui, C. H. (2021). Pulse Therapy with Vincristine and Dexamethasone for Childhood Acute Lymphoblastic Leukaemia (CCCG-ALL-2015): An Open-Label, Multicentre, Randomised, Phase 3, Non-Inferiority Trial. The Lancet Oncology, 22(9), 1322–1332.
Abstract viewed = 12 times
pdf downloaded = 12 times